Managed Account Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$36M Buy
698,462
+31,448
+5% +$1.63M 0.03% 512
2015
Q1
$33.9M Buy
667,014
+257,566
+63% +$13.3M 0.03% 517
2014
Q4
$21.8M Sell
409,448
-8,954
-2% -$456K 0.02% 677
2014
Q3
$19.1M Sell
418,402
-3,069
-0.7% -$144K 0.02% 705
2014
Q2
$20M Sell
421,471
-12,563
-3% -$584K 0.02% 680
2014
Q1
$20M Buy
434,034
+8,442
+2% +$391K 0.03% 663
2013
Q4
$20.6M Buy
425,592
+1,893
+0.4% +$88.6K 0.03% 643
2013
Q3
$18.4M Buy
423,699
+19,018
+5% +$811K 0.03% 651
2013
Q2
$16.6M Buy
+404,681
New +$16.9M 0.03% 666

Other funds holding XRAY

Managed Account Advisors's XRAY Position: Q2 2015 in Review

Managed Account Advisors increased its Dentsply Sirona (XRAY) stake by 4.7% in Q2 2015, buying an estimated $1.63M and bringing the position to 698,462 shares worth $36M. The position accounts for 0.03% of the portfolio, ranked #512.

Managed Account Advisors first reported a position in XRAY in Q2 2013 and has held it in 9 quarters since. 416 funds tracked by Wall St. Rank hold XRAY as of Q2 2015.

  • Managed Account Advisors held 698,462 shares of Dentsply Sirona worth $36M as of Q2 2015.
  • Managed Account Advisors bought 31,448 Dentsply Sirona shares in Q2 2015, an estimated $1.63M.
  • Dentsply Sirona made up 0.03% of Managed Account Advisors's portfolio in Q2 2015, its #512 holding.
  • Managed Account Advisors first reported a position in Dentsply Sirona in Q2 2013 and has held it in 9 quarters since.
  • 416 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.